Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.

Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.

Item
http://www.wikidata.org/entity/Q33504283
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft modelsPre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal DiseaseSyndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumorsCombined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumabSingle-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical ModelRadiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyEffect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.
P2860

Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.

Item
http://www.wikidata.org/entity/Q33504283
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Phase I study of intravenous L ...... with advanced adenocarcinoma.
@ast
Phase I study of intravenous L ...... with advanced adenocarcinoma.
@en
type
label
Phase I study of intravenous L ...... with advanced adenocarcinoma.
@ast
Phase I study of intravenous L ...... with advanced adenocarcinoma.
@en
prefLabel
Phase I study of intravenous L ...... with advanced adenocarcinoma.
@ast
Phase I study of intravenous L ...... with advanced adenocarcinoma.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
Phase I study of intravenous L ...... s with advanced adenocarcinoma
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921